"Je n'ai pas les mêmes perspectives d'avenir" : rembourser son prêt étudiant, une contrainte en début de carrière
- 7 min
- Publié le 18 nov. 2024
Trouvez votre formation !
Quel métier vous convient ?
Postulez chez l'Etudiant
L'outil pour les identifier
Prêt pour un entretien ?
Modèles lettres de motivation
Trouvez votre entreprise
Consultez les offres
Tous les tests carrière
Nos conseils
Les entreprises qui recrutent
Le choix de s’engager
SANTÉ - SOCIAL - HÔPITAUX, MÉDECINE
Réf. 1079607 - publié le 19 novembre 2024
FONCTION
Production, maintenance, qualité, sécurité
EXPÉRIENCE
moins d'1 an
TYPE DE CONTRAT
CDD
SECTEUR D'ACTIVITÉ DE L'ENTREPRISE
Santé - Social - Hôpitaux, Médecine
NIVEAU D'ÉTUDES
Bac +2
RÉMUNÉRATION
À définir
INFOS LOCALISATION
75005 Paris, Île-de-France
Institut Curie vous propose une offre d'emploi dans les domaines Santé - Social, Hôpitaux, Médecine à Paris.
Laboratory
The Chromosome Dynamics and Recombination team is located at Institut Curie, one of the leading cancer research institutions. The institute provides access to high-quality technological platforms such as the High-throughput Sequencing and Proteomics platforms that will be useful to the project. Aurore Sanchez, CNRS researcher in the “Chromosome Dynamics and Recombination” team led by Valérie Borde, is looking for an engineer technician (M/F) in biology. The team is composed by one PI, a CNRS researcher, an engineer, 2 assistant engineers, a postdoctoral researcher and 2 PhD students (8 people in total). https://institut-curie.org/team/borde
Research subject of the team
The team studies homologous recombination and its importance for genome stability and chromosome segregation during the formation of haploid gametes in meiosis. We use genetic, genomic, proteomic and molecular biology approaches for our studies, and apply them to the yeast Saccharomyces cerevisiae as a model organism.
Recombination occurs when a chromosome that has undergone a double-stranded DNA break (DSB) uses a homologous sequence for its repair, resulting in the exchange of DNA between parental chromosomes at the origin of genetic diversity, called crossing-over. Recombination defects have severe clinical consequences, and are linked to several diseases, such as certain hereditary cancers, genetic instability syndromes and infertility in mammals. Although meiotic recombination has been studied for decades, many of the underlying molecular processes still unclear, largely because (i) many DSB repair players remain unknown, and (2) the known actors act at different times during homologous recombination making their identification or characterization a challenging task.
However, our recent development of an experimental system that allow to separate the different stages of homologous recombination couple with cutting edge technologies already set up or in development in the lab, might finally make te identification and characterization of novels and specific actors of each step possible.
Missions
The candidate work will consist in the identification of the different actors and their involvement in the formation of crossing-overs, using an experimental system that allows the temporal separation of the first steps of recombination from the later steps. The candidate's work will be to identify the actors of these recombination steps by proteomic screens, and to test their presence at recombination sites by chromatin immunoprecipitation but also their importance by analysing the phenotype of their inactivation in vivo (gametes viability, recombination efficiency, distribution and nature of recombination events, etc.). The candidate will use techniques routinely used in the team and will implement a global proteomic approach (technique derived from BioID) to identify new actors in the last steps of recombination.
Bibliographie :
1. Ceppi, I., Dello Stritto, S., Mütze, MR., Braunshier, M., Mengoli, V., Reginato, G., Phúc Võ, HM., Jimeno, S., Acharya, A., Roy, M., Sanchez, A., Halder, S., Howard, SM., Guérois, R., Huertas, P., Noordermeer, MS., Seidel, R., and Cejka, P., 2024. Mechanism of BRCA1-BARD1 function in DNA end resection and DNA protection. Nature 634, pages 492–500 https://doi.org/10.1038/s41586-024-07909-9
2. Legrand, S., Saifudeen, A., Bordelet, H., Vernerey, J., Guille A., Bignaud, A., Thierry, A., Acquaviva, L., Gaudin, M., Sanchez, A., Johnson, D., Friedrich, A., Schacherer, J., Neale, MJ., Borde, V.,Koszul, R., Llorente, B., 2024. Absence of chromosome axis protein recruitment prevents meiotic recombination chromosome-wide in the budding yeast Lachancea kluyveri. Proc. Natl. Acad. Sci. U. S. A. 121, e2312820121 https://doi.org/10.1073/pnas.2312820121
3. Mengoli, V., Ceppi, I., Sanchez, A., Cannavo, E., Halder, S., Scaglione, S., Gaillard, PH., McHugh, P., Riesen, N., Pettazzoni, P., Cejka, P., 2022. WRN helicase and mismatch repair complexes independently and synergistically disrupt cruciform DNA structures. The EMBO Journal https://doi.org/10.15252/embj.2022111998
4. Halder, S., Sanchez, A., Ranjha, L., Reginato, G., Ceppi, I., Acharya, A., Anand, R., Cejka, P., 2022. Double-stranded DNA binding function of RAD51 in DNA protection and its regulation by BRCA2. Mol Cell https://doi.org/10.1016/j.molcel.2022.08.014
5. Dai *, J., Sanchez*, A., Adam, C., Ranjha, L., Reginato, G., Chervy, P., Tellier-Lebegue, C., Andreani, J., Guérois, R., Ropars, V., Du, M.-H.L., Maloisel, L., Martini, E., Legrand, P., Thureau, A., Cejka, P., Borde, V., Charbonnier, J.-B., 2021. Molecular basis of the dual role of the Mlh1-Mlh3 endonuclease in MMR and in meiotic crossover formation. Proc. Natl. Acad. Sci. 118. https://doi.org/10.1073/pnas.2022704118 *Equal contribution
6. Cannavo *, E., Sanchez*, A., Anand *, R., Ranjha, L., Hugener, J., Adam, C., Acharya, A., Weyland, N., Aran-Guiu, X., Charbonnier, J.-B., Hoffmann, E.R., Borde, V., Matos, J., Cejka, P., 2020. Regulation of the MLH1–MLH3 endonuclease in meiosis. Nature 586, 618–622. https://doi.org/10.1038/s41586-020-2592-2 *Equal contribution
7. Bennett, L.G., Wilkie, A.M., Antonopoulou, E., Ceppi, I., Sanchez, A., Vernon, E.G., Gamble, A., Myers, K.N., Collis, S.J., Cejka, P., Staples, C.J., 2020. MRNIP is a replication fork protection factor. Sci. Adv. 6, eaba5974. https://doi.org/10.1126/sciadv.aba5974
8. Sanchez, A., Adam, C., Rauh, F., Duroc, Y., Ranjha, L., Lombard, B., Mu, X., Wintrebert, M., Loew, D., Guarné, A., Gnan, S., Chen, C.-L., Keeney, S., Cejka, P., Guérois, R., Klein, F., Charbonnier, J.-B.,
Training and experience required
- Training and level requested: Bac + 2 minimum (DUT, BTS, a bachelor's degree)
- Professional experience requested (1-2 years)
- Knowledge of the basic techniques of biochemistry and molecular biology (cloning, genomic DNA/chromatin extraction, Western blotting, etc.)
- Expected experience in chromatin immunoprecipitation, qPCR, protein purification, and cell culture
- Knowledge in the field of DNA repair and/or meiosis appreciated
Skills required
- Understanding of reading and speaking English (level A2/B1)
- Oral communication in English (the team is international)
- Autonomy- Ability to work independently
- Good communication with team members- Aptitude for working in a team
- Scientific rigour
All our opportunities are open to people with disabilities
Contract information
Type of contract : CDD
Starting date: Middle of January 2025
Duration : 18 months
Working time : full time
Remuneration : according to the current grids
Benefits: Collective catering, reimbursement of transportation fees up to 70%, supplementary health insurance
Location of the position : Paris
Reference: NA
Contact
Please send your CV, letter of motivation and 1 reference
Publication date: 19-11-2024
Deadline for application: As soon as the position is filled
Institut Curie is an inclusive, equal opportunity employer
and is dedicated to the highest standards of research integrity.
https://euraxess.ec.europa.eu/sites/default/files/brochures/eur_21620_en-fr.pdf
Nom du recruteur : Beetween | Réf : 1pj34qg2px-1
Proposé par France Volontaires